# Xtrackers MSCI USA Health Care UCITS ETF (XSHC) **Source:** https://fundology.uk/fund/xshc · ISIN IE00BCHWNW54 · Data: TradingView (LSE closes and returns, delayed), issuer documents, ONS CPIH, FCA FIRDS ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 01/10/2026, XSHC (Xtrackers MSCI USA Health Care UCITS ETF, ISIN IE00BCHWNW54) closed at £50.76 on the London Stock Exchange. Its ongoing charge is 0.12% a year (about £12 on £10,000). Over the five years to 01/10/2026 its total return was +38.2%, or +8.0% after UK CPIH inflation. ## Summary Xtrackers MSCI USA Health Care UCITS ETF is an exchange-traded fund (ETF) from Xtrackers, launched in 2017. It tracks the MSCI USA / Health Care -SEC. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.12% a year — about £12 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is paid out to holders as cash, usually a few times a year. Latest close: **£50.76** (01/10/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | XSHC | | ISIN | IE00BCHWNW54 | | Category | Healthcare | | Type | ETF | | Provider | Xtrackers | | Tracks | MSCI USA / Health Care -SEC | | Income | Distributing | | Ongoing charge | 0.12% a year (£12 per £10,000) | | Fund size | £550m | | Launched | 2017 | | Domicile | Ireland | ## Past returns (periods to 01/10/2026) After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after ONS CPIH inflation. | Window | Return | After CPIH inflation | Measured as | |---|---|---|---| | 1 year | +22.24% | +18.40% | income reinvested | | 3 years | +23.15% | +11.13% | income reinvested | | 5 years | +38.16% | +8.00% | income reinvested | Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published. ## Calendar-year returns Calendar-year returns of Xtrackers MSCI USA Health Care UCITS ETF in pounds (price only, income paid out not included): 2022 +6.4%, 2023 −4.8%, 2024 +3.5%, 2025 +3.8%; 2026 to 30/09/2026 +10.7%. Returns of Xtrackers MSCI USA Health Care UCITS ETF in pounds (price only, income paid out not included) over the 12 months to 30/09/2026: +25.8%; to 30/09/2025: −11.8%; to 30/09/2024: +8.5%; to 30/09/2023: −3.9%; to 30/09/2022: +12.5%. | Year | Return | After CPIH inflation | Measured as | |---|---|---|---| | 2022 | +6.4% | -2.6% | Price | | 2023 | -4.8% | -8.6% | Price | | 2024 | +3.5% | -0.1% | Price | | 2025 | +3.8% | +0.2% | Price | | 2026 to 30/09/2026 | +10.7% | +7.6% | Price | ## Risk metrics | Window | Volatility | Max drawdown | |---|---|---| | 1 year | 16.98% | -12.10% | | 3 years | 14.48% | -19.35% | | 5 years | 14.05% | -19.35% | ## Largest fall Volatility of Xtrackers MSCI USA Health Care UCITS ETF in pounds, annualised from weekly returns to 30/09/2026: 17.0% over 1 year, 14.5% over 3 years, 14.0% over 5 years. Largest fall in the price of Xtrackers MSCI USA Health Care UCITS ETF since October 2021, in pounds: −19.3% from 31/01/2025 to 23/05/2025. The lowest 12-month return of Xtrackers MSCI USA Health Care UCITS ETF in pounds (price only, income paid out not included) since January 2021 was −17.2% (12 months to 08/08/2025); the highest was +27.5% (12 months to 08/04/2022). On 30/09/2026 the price of Xtrackers MSCI USA Health Care UCITS ETF was at its highest weekly close since October 2021, in pounds. ## Charges compared with similar funds Ongoing charge of Xtrackers MSCI USA Health Care UCITS ETF 0.12% a year, as of 01/10/2026: 17 of the 17 other healthcare funds charge more, 0 the same and 0 less (share classes counted once). ## Charges & eligibility - Ongoing charges figure (OCF): **0.12%** per year - ISA eligible: yes - SIPP eligible: yes ## Top holdings Largest positions (as of 01/10/2026): | Holding | Weight | |---|---| | Eli Lilly and | 15.18% | | Johnson & Johnson | 10.31% | | AbbVie | 7.45% | | Merck | 5.90% | | Unitedhealth Group | 5.45% | | Thermo Fisher Scientific | 4.04% | | Amgen | 3.66% | | Gilead Sciences | 3.01% | | Abbott Laboratories | 2.81% | | Pfizer | 2.62% | ## Where it invests Shares of the whole fund. Bonds, cash and positions the source does not classify are shown as they come, not guessed. ### By sector Added up from the holdings Xtrackers publishes, as of 01/10/2026. | Sector | Weight | |---|---| | Health Care | 99.9% | | unknown | 0.1% | ### By country Added up from the holdings Xtrackers publishes, as of 01/10/2026. | Country | Weight | |---|---| | United States | 100.0% | | Ireland | 0.1% | ### By type of asset Added up from the holdings Xtrackers publishes, as of 01/10/2026. | Type of asset | Weight | |---|---| | Equity | 99.9% | | Cash and money market | 0.1% | All 59 holdings: https://fundology.uk/fund/xshc/holdings --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.